lexapro zoloft Wo and four percent of patients discontinued due to adverse events with Lexapro and Zoloft lexapro zoloft, respectively. Adverse events occurring at an incidence of >10 percent with Lexapro or Zoloft lexapro zoloft, respectively lexapro zoloft, included ejaculation disorder (23% and 23%) lexapro zoloft, diarrhea (13% and 23%) lexapro zoloft, nausea (17% and 17%) lexapro zoloft, insomnia (14% and 17%) lexapro zoloft, libido decreased (10% and 14%) lexapro zoloft, upper respiratory tract infection (10% and 14%) lexapro zoloft, dry mouth (4% and 14%) lexapro zoloft, headache (13% and 10%) lexapro zoloft, and somnolence (12% and 6%).Study MethodologyTwo hundred twelve patients lexapro zoloft, 18 to 80 years of age with major depressive disorder (baseline MADRS score ³ 22) lexapro zoloft, participated in the double-blind study. Following a one-week lexapro zoloft, sing lexapro zoloft.
lexapro zoloft Le-blind lexapro zoloft, placebo lead-in period lexapro zoloft, patients were randomized to receive either a fixed dose of 10 mg per day of Lexapro (N=104) or a flexible dose of 50 to 200 mg per day of Zoloft (N=108). If clinically indicated lexapro zoloft, Zoloft was increased in 50 mg increments each week lexapro zoloft, as recommended in the U.S. package insert. The dose could also be decreased due to tolerability concerns. The mean dose of Zoloft at week eight was 144 mg per day. The primary efficacy variable was the change in the MADRS total score from baseline to week eight. The HAM-D Anxiety Subscale was also administered at each visit.About Lexapro Lexapro is the newest and fastest-growing selective serotonin reuptake inhibitor (SSRI) and is prescribed for more than three million patients in the U.S. Lexapro was developed by isolating the therapeutically active portion of the antidepressant CelexaTM (citalopram HBr).Lexapro was approved by the U.S. Food and Drug Administration (FDA) in August 2002 for both the initial and maintenance treatment of major depressive disorder. Lexapro is available as tablets and oral solution.As with all SSRIs lexapro zoloft, Lexapro should not be taken with monoamine oxidase inhibitors (MAOI). For more information about Lexapro lexapro zoloft, please visit http: www.lexapro.com.Forest Laboratories licenses Lexapro from H. Lundbeck A S lexapro zoloft, the Danish pharmaceutical .
lexapro zoloft Reuptake inhibitor (SSRI) and is prescribed for more than three million patients in the U.S. Lexapro was developed by isolating the therapeutically active portion of the antidepressant CelexaTM (citalopram HBr).Lexapro was approved by the U.S. Food and Drug Administration (FDA) in August 2002 for both the initial and maintenance treatment of major depressive disorder. Lexapro is available as tablets and oral solution.As with all SSRIs lexapro zoloft, Lexapro should not be taken with monoamine oxidase inhibitors (MAOI). For more information about Lexapro lexapro zoloft, please visit http: www.lexapro.com.Forest Laboratories licenses Lexapro from H. Lundbeck A S lexapro zoloft, the Danish pharmaceutical f.
lexapro zoloft 
lexapro zoloft | | | | | | lexapro zoloft
|